1. Nowak T, Handford AG. Pathophysiology: Concepts and Applications for Health Care Professionals. 3rd ed. New York, NY: McGraw Hill; 2003.
2. Hall JE. Guyton and Hall Textbook of Medical Physiology (Guyton Physiology). 14th ed. Philadelphia, PA: WB Saunders; 2021.
3. Cerwin BA. Handbook of Pathophysiology. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2014.
5. Price SA. Pathophysiology: Clinical Concepts of Disease Processes. 7th ed. St. Louis, MO: Mosby; 2014.
6. Siezak J. Cellular Interactions in Cardiac Pathophysiology: Developments in Molecular and Cellular Biochemistry. New York, NY: Springer; 2012.
9. Kern MJ, Lim MJ, Goldstein JA. Hemodynamic Rounds: Interpretation of Cardiac Pathophysiology from Pressure Waveform Analysis. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2018.
10. Bullock BA. Focus on Pathophysiology. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010.
11. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 8th ed. Maryland Heights, MO: Mosby; 2018.
12. Copstead-Kirkhorn LEC, Banasik JL. Pathophysiology. 5th ed. St. Louis, MO: Elsevier Health Sciences; 2013.
13. Brashers VL. Clinical Applications of Pathophysiology: Assessment, Diagnostic Reasoning and Management. 2nd ed. St. Louis, MO: Mosby; 2012.
14. Kupper N, Pedersen SS, Höfer S, Saner H, Oldridge N, Denollet J. Cross-cultural analysis of type D (distressed) personality in 6222 patients with ischemic heart disease: a study from the International HeartQoL Project. Int J Cardiol. 2013;166(2):327-333.
15. Nelms M, Sucher KP. Nutrition Therapy and Pathophysiology. 3rd ed. Belmont, CA: Cenage Learning; 2010.
16. Naeije R. Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovasc Dis. 2010;52(6):456-466.
18. Black JM, Hawks JH. Medical Surgical Nursing: Clinical Management for Positive Outcomes. 8th ed. Philadelphia, PA: Elsevier Saunders; 2011.
20. Mathers C, Stevens G, Mascarenhas M. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
21. U.S. Preventive Services Task Force. Hypertension in Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening. Last accessed November 15, 2021.
22. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934.
23. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76-S99.
24. U.S. Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General, 2020. Available at https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf. Last accessed November 15, 2021.
25. American Lung Association. About Freedom from Smoking. Available at https://www.lung.org/stop-smoking/join-freedom-from-smoking/about-freedom-from-smoking.html. Last accessed November 15, 2021.
26. Gassner LA, Dunn S, Piller N. Aerobic exercise and the post myocardial infarction patient: a review of the literature. Heart Lung. 2003;32(4):258-265.
27. Institute of Medicine Food and Nutrition Board. Physical Activity. Available at https://www.nap.edu/read/10490/chapter/14. Last accessed November 15, 2021.
28. Ehrman J, Gordon P, Visich P, Keteylan. Clinical Exercise Physiology. 3rd ed. Champaign, IL: Human Kinetics; 2013.
29. Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 1997;95(3):577-580.
30. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
31. O'Neill D, Britton A, Hannah MK, et al. Association of longitudinal alcohol consumption trajectories with coronary heart disease: a meta-analysis of six cohort studies using individual participant data. BMC Med. 2018;16(1):124.
32. Hines LM, Stampfer MJ, Ma J, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001;344(8):549-555.
33. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 6th ed. Champaign, IL: Human Kinetics; 2021.
34. Jacob R. Controversial Issues in Cardiac Pathophysiology: Erwin Riesch Symposium. New York, NY: Springer; 2013.
35. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-e115.
36. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
37. Griffin BP. Manual of Cardiovascular Medicine. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2018.
39. Berg SM, Bittner EA. Massachusetts General Hospital Review of Critical Care Medicine. Philadelphia, PA: Lippincott Williams and Wilkins: 2014.
40. Galvagno SM. Emergency Pathophysiology: Clinical Applications for Prehospital Care. Jackson WY: Teton NewMedia; 2013.
41. Zane RD, Kosowsky JM. Pocket Emergency Medicine (Pocket Notebook Series). 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2018.
42. Amsterdam E, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2014;64(24):e139-228.
43. Rosenbaum LS, Januzzi JL. Moving troponin testing into the 21st century: will greater sensitivity be met with greater sensibility? Cardiovasc Hematol Disord Drug Targets. 2008;8(2):118-126.
44. Markovchick VJ, Bakes KA, Buchanan J, Pons PT. Emergency Medicine Secrets. 6th ed. Philadelphia, PA: Elsevier; 2016.
45. Walraven G. Rapid EKG Interpretation. 7th ed. Upper Saddle River, NJ: Prentice Hall Health; 2011.
46. Johns Hopkins Medicine. Event Monitor. Available at https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/event-monitor. Last accessed November 15, 2021.
47. Walsh JA III, Topol EJ, Steinhubl SR. Novel wireless devices for cardiac monitoring. Circulation. 2014;130(7):573-581.
48. Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165(1):193-194.
49. Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95.e11-7.
50. Engel JM, Mehta V, Fororos R, Chavan A. Study of arrhythmia prevalence in NUVANT Mobile Cardiac Telemetry system patients. Conf Proc IEEE Eng Med Biol Soc. 2012;2440-2443.
51. Iftikhar Z, Lahdenoja O, Jafari TM, et al. Multiclass classifier based cardiovascular condition detection using smartphone mechanocardiography. Sci Rep. 2018;8(1):9344.
52. McManus DD, Chong JW, Soni A, et al. PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol. 2016;27(1):51-57.
53. Garabelli P, Stavrakis S, Po S. Smartphone-based arrhythmia monitoring. Curr Opin Cardiol. 2017;32(1):53-57.
54. American Association of Critical-Care Nurses. AACN Updates Cardiac Monitoring Practice Alerts. Available at https://www.aacn.org/newsroom/aacn-updates-cardiac-monitoring-practice-alerts. Last accessed November 15, 2021.
55. Perrino AC, Reeves ST. A Practical Approach to Transesophageal Echocardiography. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013.
56. Akinpelu D. Pharmacologic Stress Testing. Available at https://emedicine.medscape.com/article/1827166-overview. Last accessed November 15, 2021.
57. Kern MJ. Cardiac Catheterization Handbook Expert Consult-Online and Print. 5th ed. Philadelphia, PA: Elsevier Saunders; 2011.
58. Kern MJ, Sorajja P, Lim MJ. The Cardiac Catheterization Handbook. 6th ed. Philadelphia, PA: Elsevier Saunders; 2015.
61. Domino FJ. The 5-Minute Clinical Consult Standard 2015: 30-Day Enhanced Online Access + Print (The 5-Minute Consult Series). 23rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2014.
62. DiPiro J, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. 10th ed. Boston, MA: McGraw Hill; 2016.
63. Zerwekh J, Claborn JC. Mosby's Pharmacology Memory Note Cards: Visual, Mnemonic, and Memory Aids for Nurses. 4th ed. Philadelphia, PA: Mosby; 2014.
64. LeMone PT, Burke KM. Medical Surgical Nursing: Critical Thinking in Client Care. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2013.
65. Lilly LS. Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010.
66. Ford SM. Roach's Introductory Clinical Pharmacology. 11th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2017.
67. Khan GM. Cardiac Drug Therapy (Contemporary Cardiology). 8th ed. New York, NY: Humana Press; 2015.
68. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425.
69. Simons M, Alpert JS. Acute Coronary Syndrome: Terminology and Classification. Available at https://www.uptodate.com/contents/acute-coronary-syndrome-terminology-and-classification. Last accessed November 15, 2021.
70. Shah A, Gandhi D, Srivastava S, Shah KJ, Mansukhani R. Heart failure: a class review of pharmacotherapy. P T. 2017;42(7):464-472.
72. Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds). Heart failure. In: Braunwald E, Fauci AS, Kasper DL (eds). Harrison's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2011.
73. Gulanick M, Myers JL. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 9th ed. Philadelphia, PA: Mosby; 2016.
74. Ackley BJ, Ladwig GB, Flynn-Makic MB. Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 11th ed. Philadelphia, PA: Mosby; 2016.
75. Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure. Circulation. 2016;134(13):e282-e293.
77. Zipes, DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol. 2006;48(5):e247-346.
78. Ferrell BR, Coyle N, Paice J (eds). Oxford Textbook of Palliative Nursing. 4th ed. New York, NY: Oxford University Press; 2015.
79. Hayes DL. Cardiac Pacing, Defibrillation and Resynchronization: A Clinical Approach. 3rd ed. Hoboken, NJ: Wiley-Blackwell; 2013.
80. Mitchell R, Kumar V, Abbas AK, et al. Pocket Companion to Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Elsevier Saunders; 2017.
81. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541-1551.
1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013;61(4):e78-e140. Available at https://www.ahajournals.org/doi/abs/10.1161/cir.0b013e3182742cf6. Last accessed November 19, 2021.
2. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137-e161. Available at https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000509. Last accessed November 19, 2021.
3. Michigan Quality Improvement Consortium. Adults with Systolic Heart Failure. Southfield, MI: Michigan Quality Improvement Consortium; 2015. Available at http://www.mqic.org/pdf/mqic_adults_with_systolic_heart_failure_cpg.pdf. Last accessed November 19, 2021.
4. AATS Surgical Treatment of Infective Endocarditis Consensus Guidelines Writing Committee Chairs, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241-1258. Available at https://www.jtcvs.org/article/S0022-5223(17)30116-2/fulltext. Last accessed November 19, 2021.
Mention of commercial products does not indicate endorsement.